top of page

Company Origin and Objectives

Founded in 2023, Genicore Biotech Co., Ltd. is a cutting-edge technology company focusing on the biomedical field. It is currently located in the Innovation Incubation Center of Chang Gung University. Since its establishment, we have been committed to developing and improving nucleic acid aptamer screening and design technology, creating an innovative platform with a wide range of applications that goes beyond the limitations of traditional antibodies. Our aptamer technology, with its unique specificity and affinity, can accurately identify various types of biomolecules, provide customized aptamer services, and develop forward-looking products in multiple fields such as medical diagnosis, pet disease detection, food safety testing, health management, environmental testing, and academic research. We are working with semiconductor chip and rapid screening reagent platforms to apply these breakthrough technologies to practical products and services to achieve the long-term goal of improving people's health and quality of life.

MISSION STATEMENT

With nucleic acid technology at its core, we provide innovative biomedical solutions to the world, pursuing more efficient and accurate diagnosis and treatment methods.

VISION STATEMENT

We are committed to the advanced technology in disease detection and creating a new era of biomedicine. We are determined to lead the world and extend our research to every corner of the world.

VALUE PROPOSITION

For healthcare providers seeking innovative diagnostic and therapeutic solutions, our aptamer-based platform is a cutting-edge technology that ensures higher precision, reduces treatment expenses, enhances the reliability of biomedical applications, and elevates patient trust.

Technology-oriented —— We focus on scientific innovation and transform advanced nucleic acid technology into a protective force for human health.
People-oriented —— From employees to customers, we always take people's needs and well-being as the starting point for development and service.
Continuous Innovation —— Not satisfied with the status quo, we continue to explore the unknown and strive to bring forth new ideas in the field of biomedical testing.

Business Philosophy

Development Strategy

Focus on core business —— We focus on the core nucleic acid technology research and development to ensure professional and leadership in this field.
Expanding global market —— Through joint efforts with global partners, we are committed to bringing our solutions to users around the world.
Deepening partnerships —— We work closely with academic institutions, industry organisations and business partners to drive industry progress.
Cultivating talents —— Talent is our most valuable asset. We attract and cultivate industry elites through continuous education and career development opportunities.

At Genicore, every step of innovation is driven by our infinite passion for life sciences and our deep responsibility for human health. We look forward to opening a new era of biomedical testing with you.

bottom of page